申请人:SMITHKLINE BEECHAM PHARMA GmbH
公开号:EP1120417A2
公开(公告)日:2001-08-01
A method for the treatment of cerebrovascular disorders and/or disorders associated with cerebral senility and/or other disorders which method comprises the administration of an effective, non-toxic amount of a compound of formula (I):
or if appropriate a pharmaceutically acceptable salt thereof, wherein R1 and R2 each independently represent alkyl or a moiety of formula (a):
-(CH2)m-A (a)
wherein m represents zero or an integer 1, 2 or 3;
A represents a substituted or unsubstituted cyclic hydrocarbon radical; and
R3 represents a halogen atom, a nitro group, or a group -NR4R5 wherein R4 and R5 each independently represents hydrogen, alkyl or alkylcarbonyl or R4 and R5 together with the nitrogen to which they are attached forming an optionally substituted, heterocyclic group; certain novel compounds falling within formula (I) and compositions comprising such compounds.
一种治疗脑血管疾病和/或与脑衰老相关的疾病和/或其他疾病的方法,该方法包括施用有效、无毒量的式(I)化合物:
或其药学上可接受的盐,其中 R1 和 R2 各自独立地代表烷基或式(a)的分子:
-(CH2)m-A (a)
其中 m 代表零或整数 1、2 或 3;
A 代表取代或未取代的环状烃基;以及
R3 代表卤素原子、硝基或基团-NR4R5,其中 R4 和 R5 各自独立地代表氢、烷基或烷基羰基,或 R4 和 R5 与它们所连接的氮一起形成任选取代的杂环基团。